Co-Founder and COO
Gabe was introduced to healthcare and cancer treatment at a young age, when members of his family first began to succumb to the disease. This early exposure to the treatment process instilled in him a passion for science and a desire to improve modern health practices. A dual interest in science and business led him to pursue a B.S. in Neuroscience with a concentration in health economics from Oberlin College and Conservatory.
While at Oberlin, Gabe has performed extensive neuropharmacology research, as well as undertaken a range of entrepreneurial ventures. In addition to these experiences, Gabe has cultivated a thorough knowledge of the industry through his work as financial analyst for the life science market research company, BioInformatics LLC. Luke and Gabe first met at Oberlin College, where they ran an intercollegiate science magazine together.